Rituximab Completed Phase 4 Trials for Kidney Transplantation Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00782821Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients